Use of ipilimumab in the treatment of melanoma.

Use of ipilimumab in the treatment of melanoma.

Item
http://www.wikidata.org/entity/Q36571769
Oncogene withdrawal engages the immune system to induce sustained cancer regression.Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosisAn essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor TypesEvaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy.Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunityPolymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree.
P2860

Use of ipilimumab in the treatment of melanoma.

Item
http://www.wikidata.org/entity/Q36571769
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Use of ipilimumab in the treatment of melanoma.
@ast
Use of ipilimumab in the treatment of melanoma.
@en
type
label
Use of ipilimumab in the treatment of melanoma.
@ast
Use of ipilimumab in the treatment of melanoma.
@en
prefLabel
Use of ipilimumab in the treatment of melanoma.
@ast
Use of ipilimumab in the treatment of melanoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Use of ipilimumab in the treatment of melanoma.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932